Dr. Timothy Tianma Xu, MD

Dr. Xu practices at Wills Eye Hospital in Philadelphia, Pennsylvania, part of City Trusts.

Dr. Xu's NPI, 1699351635, was assigned on March 21, 2021. Dr. Xu graduated from Mayo Medical School in 2021. Dr. Xu holds Minnesota license 31532.

Dr. Xu's primary practice is Wills Eye Hospital, at 840 Walnut Street, Philadelphia, PA 19107 in Philadelphia County. The practice phone is (215) 440-3150.

Dr. Xu's primary practice is Wills Eye Hospital in Philadelphia, Pennsylvania, part of City Trusts. Dr. Xu is also affiliated with Thomas Jefferson University Hospital. The medical group on file is Mayo Clinic. Dmand AI also links Dr. Xu to 1 more hospital, 2 medical groups and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Xu practices, 4 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Xu's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Xu is licensed in Minnesota.

CMS data shows 180 Medicare services from Dr. Xu across 9 procedure codes in 2024, for 113 Medicare patients. Medicare paid $11,757 for them. Every service was in an office.

CMS counts 113 Medicare patients who saw Dr. Xu in 2024. The largest group is 65 to 74, with 53 patients. 67% of them have high blood pressure, and 52% have high cholesterol. Their average risk score is 1.29, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Xu's median patient age at 69, with 52% women.

In 2024, Dr. Xu wrote 417 Medicare Part D claims for 143 patients. 55% of them were for generic drugs. CMS names the drug for 359 of them, across 9 drugs with 11 or more claims each, at $13,040 in total drug cost. In 2023, CMS named 102 claims across 6 drugs.

Dr. Xu accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 32 papers to Dr. Xu, published from 2020 to 2025. 2023 was the busiest year, with 7. The most frequent topics are Minnesota, Age Distribution and Melanoma. Dr. Xu has published most often in Am J Ophthalmol. Dr. Xu's most frequent co-authors are Lauren A. Dalvin, MD, Wendy Meredith Smith, MD and Keith H. Baratz, MD.

CMS Open Payments shows 12 general payments to Dr. Xu from 5 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 54% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $700.

Dr. Xu graduated from Mayo Medical School in 2021.